Biopharmaceutical company
| Year | Client | Period | Income | Expenses | Doc |
|---|---|---|---|---|---|
| 2024 | ARDELYX, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | $530,000 | |
| 2023 | ARDELYX, INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | $500,000 | |
| 2023 | ARDELYX, INC. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | $460,000 | |
| 2023 | ARDELYX, INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | $310,000 | |
| 2023 | ARDELYX, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | $240,000 | |
| 2022 | ARDELYX, INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report (No Activity) |
— | $130,000 | |
| 2022 | ARDELYX, INC. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report (No Activity) |
— | $130,000 | |
| 2022 | ARDELYX, INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report (No Activity) |
— | $130,000 | |
| 2022 | ARDELYX, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report (No Activity) |
— | $130,000 | |
| 2021 | ARDELYX, INC. |
4th Quarter (Oct 1 - Dec 31) AMENDED |
— | $260,000 |
| Client | Filings | Total Income |
|---|---|---|
| ARDELYX, INC. | 26 | — |